Serum Potassium Monitoring Using AI-Enabled Smartwatch Electrocardiograms.

IF 8 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
I-Min Chiu, Po-Jung Wu, Huan Zhang, J Weston Hughes, Albert J Rogers, Laleh Jalilian, Marco Perez, Chun-Hung Richard Lin, Chien-Te Lee, James Zou, David Ouyang
{"title":"Serum Potassium Monitoring Using AI-Enabled Smartwatch Electrocardiograms.","authors":"I-Min Chiu, Po-Jung Wu, Huan Zhang, J Weston Hughes, Albert J Rogers, Laleh Jalilian, Marco Perez, Chun-Hung Richard Lin, Chien-Te Lee, James Zou, David Ouyang","doi":"10.1016/j.jacep.2024.07.023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hyperkalemia, characterized by elevated serum potassium levels, heightens the risk of sudden cardiac death, particularly increasing risk for individuals with chronic kidney disease and end-stage renal disease (ESRD). Traditional laboratory test monitoring is resource-heavy, invasive, and unable to provide continuous tracking. Wearable technologies like smartwatches with electrocardiogram (ECG) capabilities are emerging as valuable tools for remote monitoring, potentially allowing for personalized monitoring with artificial intelligence (AI)-ECG interpretation.</p><p><strong>Objectives: </strong>The purpose of this study was to develop an AI-ECG algorithm to predict serum potassium level in ESRD patients with smartwatch-generated ECG waveforms.</p><p><strong>Methods: </strong>A cohort of 152,508 patients with 293,557 ECGs paired serum potassium levels obtained within 1 hour at Cedars Sinai Medical Center was used to train an AI-ECG model (\"Kardio-Net\") to predict serum potassium level. The model was further fine-tuned on 4,337 ECGs from 1,463 patients with ESRD using inputs from 12- and single-lead ECGs. Kardio-Net was evaluated in held-out test cohorts from Cedars Sinai Medical Center and Stanford Healthcare (SHC) as well as a prospective international cohort of 40 ESRD patients with smartwatch ECGs at Chang Gung Memorial Hospital.</p><p><strong>Results: </strong>The Kardio-Net, when applied to 12-lead ECGs, identified severe hyperkalemia (>6.5 mEq/L) with an AUC of 0.852 (95% CI: 0.745-0.956) and a mean absolute error (MAE) of 0.527 mEq/L. In external validation at SHC, the model achieved an AUC of 0.849 (95% CI: 0.823-0.875) and an MAE of 0.599 mEq/L. For single-lead ECGs, Kardio-Net detected severe hyperkalemia with an AUC of 0.876 (95% CI: 0.765-0.987) in the primary cohort and had an MAE of 0.575 mEq/L. In the external SHC validation, the AUC was 0.807 (95% CI: 0.778-0.835) with an MAE of 0.740 mEq/L. Using prospectively obtained smartwatch data, the AUC was 0.831 (95% CI: 0.693-0.975), with an MAE of 0.580 mEq/L.</p><p><strong>Conclusions: </strong>We validate a deep learning model to predict serum potassium levels from both 12-lead ECGs and single-lead smartwatch data, demonstrating its utility for remote monitoring of hyperkalemia.</p>","PeriodicalId":14573,"journal":{"name":"JACC. Clinical electrophysiology","volume":" ","pages":""},"PeriodicalIF":8.0000,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Clinical electrophysiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jacep.2024.07.023","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hyperkalemia, characterized by elevated serum potassium levels, heightens the risk of sudden cardiac death, particularly increasing risk for individuals with chronic kidney disease and end-stage renal disease (ESRD). Traditional laboratory test monitoring is resource-heavy, invasive, and unable to provide continuous tracking. Wearable technologies like smartwatches with electrocardiogram (ECG) capabilities are emerging as valuable tools for remote monitoring, potentially allowing for personalized monitoring with artificial intelligence (AI)-ECG interpretation.

Objectives: The purpose of this study was to develop an AI-ECG algorithm to predict serum potassium level in ESRD patients with smartwatch-generated ECG waveforms.

Methods: A cohort of 152,508 patients with 293,557 ECGs paired serum potassium levels obtained within 1 hour at Cedars Sinai Medical Center was used to train an AI-ECG model ("Kardio-Net") to predict serum potassium level. The model was further fine-tuned on 4,337 ECGs from 1,463 patients with ESRD using inputs from 12- and single-lead ECGs. Kardio-Net was evaluated in held-out test cohorts from Cedars Sinai Medical Center and Stanford Healthcare (SHC) as well as a prospective international cohort of 40 ESRD patients with smartwatch ECGs at Chang Gung Memorial Hospital.

Results: The Kardio-Net, when applied to 12-lead ECGs, identified severe hyperkalemia (>6.5 mEq/L) with an AUC of 0.852 (95% CI: 0.745-0.956) and a mean absolute error (MAE) of 0.527 mEq/L. In external validation at SHC, the model achieved an AUC of 0.849 (95% CI: 0.823-0.875) and an MAE of 0.599 mEq/L. For single-lead ECGs, Kardio-Net detected severe hyperkalemia with an AUC of 0.876 (95% CI: 0.765-0.987) in the primary cohort and had an MAE of 0.575 mEq/L. In the external SHC validation, the AUC was 0.807 (95% CI: 0.778-0.835) with an MAE of 0.740 mEq/L. Using prospectively obtained smartwatch data, the AUC was 0.831 (95% CI: 0.693-0.975), with an MAE of 0.580 mEq/L.

Conclusions: We validate a deep learning model to predict serum potassium levels from both 12-lead ECGs and single-lead smartwatch data, demonstrating its utility for remote monitoring of hyperkalemia.

利用人工智能智能手表心电图监测血清钾。
背景:以血清钾水平升高为特征的高钾血症会增加心脏性猝死的风险,尤其会增加慢性肾病和终末期肾病 (ESRD) 患者的风险。传统的实验室测试监测耗费大量资源,具有侵入性,而且无法提供连续跟踪。具有心电图(ECG)功能的智能手表等可穿戴技术正在成为远程监测的重要工具,有可能通过人工智能(AI)-ECG 解读实现个性化监测:本研究旨在开发一种人工智能心电图算法,利用智能手表生成的心电图波形预测 ESRD 患者的血清钾水平:西奈雪松医疗中心(Cedars Sinai Medical Center)在1小时内采集了152,508名患者的293,557张心电图,这些心电图与血清钾水平成对,用于训练预测血清钾水平的人工智能心电图模型("Kardio-Net")。利用 12 导联和单导联心电图的输入,对来自 1463 名 ESRD 患者的 4337 张心电图进行了进一步微调。Kardio-Net 在西达斯西奈医疗中心和斯坦福医疗保健公司(SHC)的保留测试队列以及长庚纪念医院 40 名 ESRD 患者的智能手表心电图前瞻性国际队列中进行了评估:将 Kardio-Net 应用于 12 导联心电图时,可识别严重高钾血症(>6.5 mEq/L),AUC 为 0.852(95% CI:0.745-0.956),平均绝对误差 (MAE) 为 0.527 mEq/L。在 SHC 的外部验证中,该模型的 AUC 为 0.849(95% CI:0.823-0.875),MAE 为 0.599 mEq/L。对于单导联心电图,Kardio-Net 在主要队列中检测出严重高钾血症的 AUC 为 0.876(95% CI:0.765-0.987),MAE 为 0.575 mEq/L。在外部 SHC 验证中,AUC 为 0.807(95% CI:0.778-0.835),MAE 为 0.740 mEq/L。使用前瞻性获得的智能手表数据,AUC 为 0.831(95% CI:0.693-0.975),MAE 为 0.580 mEq/L:我们验证了通过 12 导联心电图和单导联智能手表数据预测血清钾水平的深度学习模型,证明了其在远程监测高钾血症方面的实用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JACC. Clinical electrophysiology
JACC. Clinical electrophysiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
10.30
自引率
5.70%
发文量
250
期刊介绍: JACC: Clinical Electrophysiology is one of a family of specialist journals launched by the renowned Journal of the American College of Cardiology (JACC). It encompasses all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. Submissions of original research and state-of-the-art reviews from cardiology, cardiovascular surgery, neurology, outcomes research, and related fields are encouraged. Experimental and preclinical work that directly relates to diagnostic or therapeutic interventions are also encouraged. In general, case reports will not be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信